These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19549770)
1. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma. Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770 [TBL] [Abstract][Full Text] [Related]
2. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169 [TBL] [Abstract][Full Text] [Related]
4. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells. Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709 [TBL] [Abstract][Full Text] [Related]
6. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. Bharadwaj U; Zhang R; Yang H; Li M; Doan LX; Chen C; Yao Q J Surg Res; 2005 Jul; 127(1):29-38. PubMed ID: 15964302 [TBL] [Abstract][Full Text] [Related]
7. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors. Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716 [TBL] [Abstract][Full Text] [Related]
8. Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells. Yanagawa Y; Onoé K Immunology; 2006 Apr; 117(4):526-35. PubMed ID: 16556267 [TBL] [Abstract][Full Text] [Related]
9. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II. Yang L; Du C; Chen T; Li S; Nie W; Zhu W; Fan F; Zhu J; Yan H Mol Immunol; 2012 May; 51(1):51-6. PubMed ID: 22387269 [TBL] [Abstract][Full Text] [Related]
10. Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. Mitchell D; Yong M; Schroder W; Black M; Tirrell M; Olive C J Infect Dis; 2010 Jul; 202(2):318-29. PubMed ID: 20524851 [TBL] [Abstract][Full Text] [Related]
11. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. Aicher A; Shu GL; Magaletti D; Mulvania T; Pezzutto A; Craxton A; Clark EA J Immunol; 1999 Dec; 163(11):5786-95. PubMed ID: 10570261 [TBL] [Abstract][Full Text] [Related]
12. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J; Saffold S; Cao X; Krauss J; Chen W J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528 [TBL] [Abstract][Full Text] [Related]
13. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017 [TBL] [Abstract][Full Text] [Related]
14. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043 [TBL] [Abstract][Full Text] [Related]
15. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169 [TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma. Lee TH; Cho YH; Lee JD; Yang WI; Shin JL; Lee MG Immunol Lett; 2006 Jul; 106(1):19-26. PubMed ID: 16647143 [TBL] [Abstract][Full Text] [Related]
17. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Gleisner MA; Rosemblatt M; Fierro JA; Bono MR Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264 [TBL] [Abstract][Full Text] [Related]
18. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. Nakahara T; Moroi Y; Uchi H; Furue M J Dermatol Sci; 2006 Apr; 42(1):1-11. PubMed ID: 16352421 [TBL] [Abstract][Full Text] [Related]
19. Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression. Díaz-Valdés N; Basagoiti M; Dotor J; Aranda F; Monreal I; Riezu-Boj JI; Borrás-Cuesta F; Sarobe P; Feijoó E Cancer Res; 2011 Feb; 71(3):812-21. PubMed ID: 21159663 [TBL] [Abstract][Full Text] [Related]